Cargando…
Inhibition of Glioblastoma Growth by the Thiadiazolidinone Compound TDZD-8
BACKGROUND: Thiadiazolidinones (TDZD) are small heterocyclic compounds first described as non-ATP competitive inhibitors of glycogen synthase kinase 3β (GSK-3β). In this study, we analyzed the effects of 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione (TDZD-8), on murine GL261 cells growth in vitr...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2975629/ https://www.ncbi.nlm.nih.gov/pubmed/21079728 http://dx.doi.org/10.1371/journal.pone.0013879 |
_version_ | 1782190949985681408 |
---|---|
author | Aguilar-Morante, Diana Morales-Garcia, Jose Angel Sanz-SanCristobal, Marina Garcia-Cabezas, Miguel Angel Santos, Angel Perez-Castillo, Ana |
author_facet | Aguilar-Morante, Diana Morales-Garcia, Jose Angel Sanz-SanCristobal, Marina Garcia-Cabezas, Miguel Angel Santos, Angel Perez-Castillo, Ana |
author_sort | Aguilar-Morante, Diana |
collection | PubMed |
description | BACKGROUND: Thiadiazolidinones (TDZD) are small heterocyclic compounds first described as non-ATP competitive inhibitors of glycogen synthase kinase 3β (GSK-3β). In this study, we analyzed the effects of 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione (TDZD-8), on murine GL261 cells growth in vitro and on the growth of established intracerebral murine gliomas in vivo. METHODOLOGY/PRINCIPAL FINDINGS: Our data show that TDZD-8 decreased proliferation and induced apoptosis of GL261 glioblastoma cells in vitro, delayed tumor growth in vivo, and augmented animal survival. These effects were associated with an early activation of extracellular signal-regulated kinase (ERK) pathway and increased expression of EGR-1 and p21 genes. Also, we observed a sustained activation of the ERK pathway, a concomitant phosphorylation and activation of ribosomal S6 kinase (p90RSK) and an inactivation of GSK-3β by phosphorylation at Ser 9. Finally, treatment of glioblastoma stem cells with TDZD-8 resulted in an inhibition of proliferation and self-renewal of these cells. CONCLUSIONS/SIGNIFICANCE: Our results suggest that TDZD-8 uses a novel mechanism to target glioblastoma cells, and that malignant progenitor population could be a target of this compound. |
format | Text |
id | pubmed-2975629 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-29756292010-11-15 Inhibition of Glioblastoma Growth by the Thiadiazolidinone Compound TDZD-8 Aguilar-Morante, Diana Morales-Garcia, Jose Angel Sanz-SanCristobal, Marina Garcia-Cabezas, Miguel Angel Santos, Angel Perez-Castillo, Ana PLoS One Research Article BACKGROUND: Thiadiazolidinones (TDZD) are small heterocyclic compounds first described as non-ATP competitive inhibitors of glycogen synthase kinase 3β (GSK-3β). In this study, we analyzed the effects of 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione (TDZD-8), on murine GL261 cells growth in vitro and on the growth of established intracerebral murine gliomas in vivo. METHODOLOGY/PRINCIPAL FINDINGS: Our data show that TDZD-8 decreased proliferation and induced apoptosis of GL261 glioblastoma cells in vitro, delayed tumor growth in vivo, and augmented animal survival. These effects were associated with an early activation of extracellular signal-regulated kinase (ERK) pathway and increased expression of EGR-1 and p21 genes. Also, we observed a sustained activation of the ERK pathway, a concomitant phosphorylation and activation of ribosomal S6 kinase (p90RSK) and an inactivation of GSK-3β by phosphorylation at Ser 9. Finally, treatment of glioblastoma stem cells with TDZD-8 resulted in an inhibition of proliferation and self-renewal of these cells. CONCLUSIONS/SIGNIFICANCE: Our results suggest that TDZD-8 uses a novel mechanism to target glioblastoma cells, and that malignant progenitor population could be a target of this compound. Public Library of Science 2010-11-08 /pmc/articles/PMC2975629/ /pubmed/21079728 http://dx.doi.org/10.1371/journal.pone.0013879 Text en Aguilar-Morante et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Aguilar-Morante, Diana Morales-Garcia, Jose Angel Sanz-SanCristobal, Marina Garcia-Cabezas, Miguel Angel Santos, Angel Perez-Castillo, Ana Inhibition of Glioblastoma Growth by the Thiadiazolidinone Compound TDZD-8 |
title | Inhibition of Glioblastoma Growth by the Thiadiazolidinone Compound TDZD-8 |
title_full | Inhibition of Glioblastoma Growth by the Thiadiazolidinone Compound TDZD-8 |
title_fullStr | Inhibition of Glioblastoma Growth by the Thiadiazolidinone Compound TDZD-8 |
title_full_unstemmed | Inhibition of Glioblastoma Growth by the Thiadiazolidinone Compound TDZD-8 |
title_short | Inhibition of Glioblastoma Growth by the Thiadiazolidinone Compound TDZD-8 |
title_sort | inhibition of glioblastoma growth by the thiadiazolidinone compound tdzd-8 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2975629/ https://www.ncbi.nlm.nih.gov/pubmed/21079728 http://dx.doi.org/10.1371/journal.pone.0013879 |
work_keys_str_mv | AT aguilarmorantediana inhibitionofglioblastomagrowthbythethiadiazolidinonecompoundtdzd8 AT moralesgarciajoseangel inhibitionofglioblastomagrowthbythethiadiazolidinonecompoundtdzd8 AT sanzsancristobalmarina inhibitionofglioblastomagrowthbythethiadiazolidinonecompoundtdzd8 AT garciacabezasmiguelangel inhibitionofglioblastomagrowthbythethiadiazolidinonecompoundtdzd8 AT santosangel inhibitionofglioblastomagrowthbythethiadiazolidinonecompoundtdzd8 AT perezcastilloana inhibitionofglioblastomagrowthbythethiadiazolidinonecompoundtdzd8 |